Cargando…

Evaluation of potential immunogenicity differences between Pandemrix™ and Arepanrix™

In retrospective observational studies, an increased relative risk of incident narcolepsy was observed in some European countries among recipients of the AS03-adjuvanted, A(H1N1)pdm09, inactivated, detergent-split virion vaccine Pandemrix™ manufactured in Dresden, Germany (D-Pan H1N1). A similar inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Canelle, Quentin, Dewé, Walthère, Innis, Bruce L., van der Most, Robbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027709/ https://www.ncbi.nlm.nih.gov/pubmed/27105343 http://dx.doi.org/10.1080/21645515.2016.1168954

Ejemplares similares

Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials
por: van der Most, Robbert G., et al.
Publicado: (2017)

Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
por: Beran, Jiří, et al.
Publicado: (2013)

Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: Pooled analysis of 28 clinical trials
por: Vaughn, David W, et al.
Publicado: (2014)

Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival
por: Hallberg, Pär, et al.
Publicado: (2019)

Pandemrix™ and narcolepsy: A critical appraisal of the observational studies
por: Verstraeten, Thomas, et al.
Publicado: (2015)

Using a Facebook Forum to Cope With Narcolepsy After Pandemrix Vaccination: Infodemiology Study
por: Blomberg, Karin, et al.
Publicado: (2019)

Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial
por: Rümke, Hans C, et al.
Publicado: (2013)

ImmunogenIcity of thE PandemRIX A (H1N1) 2009 Influenza vaccine in hemodialysed and renal transplanted patients
por: Hombrouck, A, et al.
Publicado: (2011)

No evidence of autoimmunity to human OX(1) or OX(2) orexin receptors in Pandemrix-vaccinated narcoleptic children
por: Melén, Krister, et al.
Publicado: (2020)

Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases
por: Luo, Guo, et al.
Publicado: (2017)

HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy
por: Lind, Alexander, et al.
Publicado: (2019)

Registry Cohort Study to Determine Risk for Multiple Sclerosis after Vaccination for Pandemic Influenza A(H1N1) with Arepanrix, Manitoba, Canada
por: Mahmud, Salaheddin M., et al.
Publicado: (2018)

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant
por: Langley, Joanne M., et al.
Publicado: (2017)

Correction: Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases
por: Luo, Guo, et al.
Publicado: (2019)

Antigenic Differences between AS03 Adjuvanted Influenza A (H1N1) Pandemic Vaccines: Implications for Pandemrix-Associated Narcolepsy Risk
por: Vaarala, Outi, et al.
Publicado: (2014)

Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix(™)and Narcolepsy
por: Bollaerts, Kaatje, et al.
Publicado: (2016)

Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children
por: Elding Larsson, Helena, et al.
Publicado: (2017)

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children
por: Langley, Joanne M., et al.
Publicado: (2013)

Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis
por: Ruiz-Palacios, Guillermo M., et al.
Publicado: (2016)

Quality of life and trust among young people with narcolepsy and their families, after the Pandemrix® vaccination: protocol for a case-control study
por: Blomberg, Karin, et al.
Publicado: (2017)

UNDERSTANDING AND ADDRESSING IMMUNOSENESCENCE
por: Van Der Most, Robbert
Publicado: (2019)

Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease
por: Benoit, Anne, et al.
Publicado: (2015)

Hamster neogenin, a host-cell protein contained in a respiratory syncytial virus candidate vaccine, induces antibody responses in rabbits but not in clinical trial participants
por: Steff, Ann-Muriel, et al.
Publicado: (2020)

Safety and immunogenicity of candidate vaccine M72/AS01(E) in adolescents in a TB endemic setting
por: Penn-Nicholson, Adam, et al.
Publicado: (2015)

Loss of antigen cross-presentation after complete tumor resection is associated with the generation of protective tumor-specific CD8(+) T-cell immunity
por: Brown, Matthew D., et al.
Publicado: (2012)

H1N1 viral proteome peptide microarray predicts individuals at risk for H1N1 infection and segregates infection versus Pandemrix® vaccination
por: Ambati, Aditya, et al.
Publicado: (2015)

Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1
por: Vuorela, A., et al.
Publicado: (2021)

Narcolepsy and H1N1 influenza immunology a decade later: What have we learned?
por: Buonocore, Sofia M., et al.
Publicado: (2022)

Role and plasticity of Th1 and Th17 responses in immunity to Staphylococcus aureus
por: Ferraro, Alessandra, et al.
Publicado: (2019)

No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix Vaccination Campaign in Finland
por: Melén, Krister, et al.
Publicado: (2013)

Increased muscle activity during sleep and more RBD symptoms in H1N1-(Pandemrix)-vaccinated narcolepsy type 1 patients compared with their non-narcoleptic siblings
por: Viste, Rannveig, et al.
Publicado: (2022)

Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine
por: Moris, Philippe, et al.
Publicado: (2017)

A Comparison of Different Modeling Techniques in Predicting Mortality With the Tilburg Frailty Indicator: Longitudinal Study
por: van der Ploeg, Tjeerd, et al.
Publicado: (2022)

A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age
por: Pavia-Ruz, Noris, et al.
Publicado: (2013)

Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses
por: Coccia, Margherita, et al.
Publicado: (2022)

Potential Immunogenic Polypeptides of Burkholderia pseudomallei Identified by Shotgun Expression Library and Evaluation of Their Efficacy for Serodiagnosis of Melioidosis
por: Puah, Suat Moi, et al.
Publicado: (2013)

Vaccination as a preventative measure contributing to immune fitness
por: Laupèze, Béatrice, et al.
Publicado: (2021)

Gastroenteritis Forecasting Assessing the Use of Web and Electronic Health Record Data With a Linear and a Nonlinear Approach: Comparison Study
por: Poirier, Canelle, et al.
Publicado: (2023)

Immunogenicity of targeted lentivectors
por: Goyvaerts, Cleo, et al.
Publicado: (2014)

Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study
por: Arnheim-Dahlström, Lisen, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8qu155sjgaa6bs96g5nlnddsc8